ArticleJournal of experimental & clinical cancer research : CR2026
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma.
Andrew Farrell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.